Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

GlobeImmune, Inc. GBIM OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
9/100
0/3 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

GlobeImmune, Inc. (GBIM) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 8/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth ?/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

GBIM SharesGrow Score Overview

28/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 0/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GBIM

—
VALUE N/A
N/A
No analyst coverage available for this stock.
—
GROWTH N/A
N/A
No analyst coverage available for this stock.
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
28/100
GBIM: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0005
Volume756
Avg Volume (30D)136
Market Cap$575.00
Beta (1Y)-200.46
Share Statistics
IPO Date2014-07-02
Employees2
CEODonald Bellgrau
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS37957B1008

Price Chart

Track all markets on TradingView
GBIM
GlobeImmune, Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.00

People Also View

IMGN
IMGN
ImmunoGen, Inc.
$31.24
+0.02%
 IBRX
IBRX
ImmunityBio, Inc.
$7.60
+4.11%
 CDTX
CDTX
Cidara Therapeutics, Inc.
$221.38
+0.00%
 IOVA
IOVA
Iovance Biotherapeutics, Inc.
$3.64
+5.20%
 LXRX
LXRX
Lexicon Pharmaceuticals, Inc.
$1.75
+2.34%
 PLX
PLX
Protalix BioTherapeutics, Inc.
$2.36
+3.06%
 MCRB
MCRB
Seres Therapeutics, Inc.
$8.61
+0.35%
 GRTX
GRTX
Galera Therapeutics, Inc.
$0.08
+87.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message